Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03083197

Scrub Typhus Antibiotic Resistance Trial

The Scrub Typhus Antibiotic Resistance Trial (START) Comparing Doxycycline and Azithromycin Treatment Modalities in Areas of Reported Antimicrobial Resistance for Scrub Typhus

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
177 (estimated)
Sponsor
University of Oxford · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

Study type: Randomized Control Treatment Trial Study population: Male and female patients with ≥15 years of age and acute scrub typhus Duration: 2 years Study Design: Prospective, open-label, randomized-controlled treatment trial in patients ≥15 years old admitted to hospital with acute scrub typhus. Randomization into 3 oral treatment arms (each n=59 patients, total n=177): i) 7 days of doxycycline, ii) 3 days of doxycycline, and iii) 3 days of azithromycin Primary Objective: To evaluate the clinical and microbiological responses in scrub typhus patients to three oral treatment regimens: 7 days of doxycycline, 3 days of doxycycline, and 3 days of azithromycin Secondary Objectives: 1. To perform pharmacokinetic/pharmacodynamics (PK/PD) characterization of the therapeutic responses for doxycycline and azithromycin, incl. serial bacterial load measurements. 2. To define clinical, bacterial, pathophysiological and pharmacological factors associated with disease severity, fever-clearance times (FCT), treatment failures and relapse/re-infection. 3. To determine the minimum inhibitory concentrations (MIC) of clinical Orientia tsutsugamushi isolates to doxycycline, azithromycin and chloramphenicol, using in vitro growth-inhibition assays 4. To genotype all clinical isolates using whole genome sequencing for comparative genomics. 5. To dissect the natural immune response in scrub typhus, using antigen-specific cellular immune and antibody studies, and cytokine profiling

Detailed description

The funder is USAMRMC - MIDRP and Grant No. DHP-Award D6.7\_15\_C2\_I\_15\_J9\_1317

Conditions

Interventions

TypeNameDescription
DRUGDoxycycline 7 daysloading dose 200mg PO, then 100mg PO every 12 hours for 7 days
DRUGDoxycycline 3 daysloading dose 200mg PO, then 100mg PO every 12 hours for 3 days
DRUGAzithromycin 3 daysloading dose 1000mg PO on day 1, then 500mg PO every 24 hours on days 2 and 3

Timeline

Start date
2017-10-15
Primary completion
2026-10-01
Completion
2026-10-01
First posted
2017-03-17
Last updated
2026-01-12

Locations

2 sites across 1 country: Thailand

Source: ClinicalTrials.gov record NCT03083197. Inclusion in this directory is not an endorsement.